Basal Cell Carcinoma vs Squamous Cell Carcinoma
Basal Cell Carcinoma and Squamous Cell Carcinoma are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.
Basal Cell Carcinoma vs Squamous Cell Carcinoma at a glance
- Basal Cell Carcinoma: Most common human cancer; slow-growing locally invasive tumor of basal keratinocytes driven by UV-induced PTCH/Hedgehog mutations.
- Squamous Cell Carcinoma: Second most common skin cancer; UV-driven keratinocyte malignancy with real metastatic potential, especially in immunosuppressed.
Keep comparing — start your free trial
You've used your 2 free previews. Create your free account to see the full Basal Cell Carcinoma vs Squamous Cell Carcinoma comparison — plus all 514 diagnosis outlines, 6,400+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.
Side-by-side comparison
| Feature | Basal Cell Carcinoma | Squamous Cell Carcinoma |
|---|---|---|
| At a glance | Most common human cancer; slow-growing locally invasive tumor of basal keratinocytes driven by UV-induced PTCH/Hedgehog mutations. | Second most common skin cancer; UV-driven keratinocyte malignancy with real metastatic potential, especially in immunosuppressed. |
| Classic presentation | Pearly translucent nodule with rolled border, telangiectasias, and central ulcer on a sun-exposed area of an older fair-skinned adult.; Often asymptomatic; patient notices 'pimple' or 'sore that won't heal' for months to years; Occasional bleeding with minor trauma; rarely painful unless ulcerated/infected; Nodular BCC (most common,… | Hyperkeratotic indurated nodule with central ulceration on sun-damaged skin of an older adult, often arising from a pre-existing actinic keratosis.; Often asymptomatic; new growth, non-healing 'sore', or growth in a chronic scar/ulcer; Tenderness, bleeding, crusting; Pain, paresthesia, motor weakness → perineural invasion; Bowen disease… |
| Workup / key labs | Histopathologic confirmation of basaloid tumor cells in palisading nests with retraction artifact and myxoid stroma.; Tissue diagnosis required — skin biopsy (shave or punch); Histopathology subtype determines management (nodular, superficial, morpheaform/infiltrative, basosquamous, micronodular) | Histopathologic confirmation; AJCC 8th edition staging + NCCN/BWH risk stratification; Skin biopsy (shave, punch, or excisional) — tissue diagnosis required; Histopathology determines depth, differentiation (well/moderate/poor), perineural invasion, and high-risk features |
| Imaging | CT/MRI only for advanced or recurrent tumors with suspected perineural invasion or deep tissue involvement; Routine imaging not indicated for typical primary BCC | Lymph node ultrasound + FNA if palpable lymphadenopathy or high-risk tumor; CT/MRI for large tumors, perineural invasion symptoms, deep tissue/bone involvement; PET/CT for staging in advanced disease; Sentinel lymph node biopsy considered for high-risk SCC (>2 cm, >6 mm depth, poor differentiation, perineural invasion,… |
| First-line treatment | Surgical excision with 4 mm margins for low-risk primary BCC (cure rate ~95%); Mohs micrographic surgery (preferred for high-risk BCC): face (especially H-zone — central face, periocular, periauricular, perinasal), morpheaform/infiltrative subtypes, recurrent tumors, large tumors (>2 cm), positive margins after standard excision — cure… | Low-risk primary cutaneous SCC: surgical excision with 4-6 mm clinical margins (cure rate >95%); Mohs micrographic surgery (preferred for high-risk SCC): face/H-zone, ears, lips, genitalia, perineural invasion, recurrent, >2 cm, depth >6 mm, poor differentiation, immunosuppressed host; ED&C for small (<1 cm) low-risk SCC in situ on… |
Drill Basal Cell Carcinoma vs Squamous Cell Carcinoma questions on FirstPassPA
Turn this comparison into retention. 6,400+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Try today's free questionEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.